While genomics remains foundational, proteomics is offering a deeper understanding of the molecules that drive cancer.

Steve Hilton and Xavier Becerra were overall frontrunners, but Tom Steyer and Chad Bianco excelled in some counties.

But far too many companies are still playing by the old playbook—thinking that success goes to whomever builds the best ...